logo

Zydus Lifesciences Ltd. Financials

15:59 Sep 12

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1044.75
+1.15 (+0.11%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1044.75
+1.15 (+0.11%)
15:59 Sep 12
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

13

Weakness

1

Opportunity

0

Threats

1

18.89 %

ROE %

12.16 %

ROA %

45.56

EPS

238.10

BVPS

19.47 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
15265.2 17237.4 19547.4 23241.5 23607.7
Operating Expenses +
11924.5 13377.5 14163.1 16183 16544.7
Raw Material
5907.5 6072 6478.4 6522.9 6762.1
Increase Decrease in Cost
-362.3 238.1 -250.2 -184.9 -220.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2434.1 2765.6 3137.6 3680.6 3802.3
Miscellaneous Expenses
7674.4 8200.6 8593.1 10464.4 6201
Operating Profit
3340.7 3859.9 5384.3 7058.5 7063
Other Income
224.7 186.6 284.1 269.5 361.2
Depreciation
713 722.7 764.1 915.8 938.6
Interest
127 129.9 81.2 165.9 218.4
Profit before tax and exceptio..
2725.4 3193.9 4823.1 6246.3 6267.2
Exceptional Items
112.7 -604.2 -14.2 -219.6 -219.6
PBT
2838.1 2589.7 4808.9 6026.7 6486.8
Provision for Taxation
511.7 587.8 977.5 1411.9 1409.8
Net Profit
4572.1 1997.3 3854.4 4614.8 4637.8
NET Profit after MI
4487.3 1960.3 3859.5 4525.5 4584.1
EPS
43.83 19.3 38.14 44.97 45.45
Operating Profit Margin (%)
21.88 22.39 27.54 30.37 29.92
Net Profit Margin (%)
29.4 11.37 19.74 19.47 19.42

Zydus Lifesciences Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Jun 25 Mar 25 Dec 24 Sep 24 Jun 24
Promoter 75.00 75.00 75.00 75.00 75.00
FII 7.10 7.30 7.50 7.50 5.60
MF 5.60 6.40 6.30 6.60 7.20
Others 5.60 4.60 4.40 4.10 5.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: